Segment Deep-Dive: Vaccines, Animal-Derived Excipients, and the Rise of Recombinant and Monoclonal Antibody Applications
To fully grasp the explosive dynamics of the Biologic Excipient Market, a detailed examination of its key segments is essential. Valued at USD 10.27 Billion in 2024 and projected to reach USD 52.13 Billion by 2035, the market is a complex landscape of different sources, forms, and end-use applications . While vaccines and animal-derived excipients currently command the largest market shares,...
0 Kommentare 0 Geteilt 114 Ansichten 0 Bewertungen